MCL coexpression mm9:449: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 6: | Line 6: | ||
|ontology_enrichment_disease= | |ontology_enrichment_disease= | ||
|ontology_enrichment_uberon=UBERON:0000026!3.27e-09!12;UBERON:0004708!3.27e-09!12;UBERON:0002101!3.27e-09!12;UBERON:0004357!3.27e-09!12;UBERON:0004347!3.27e-09!12;UBERON:0005732!3.27e-09!12;UBERON:0005733!3.27e-09!12;UBERON:0003102!5.06e-09!22;UBERON:0010707!3.02e-08!13;UBERON:0002102!7.15e-07!7;UBERON:0004710!7.15e-07!7;UBERON:0005419!7.15e-07!7;UBERON:0005417!7.15e-07!7;UBERON:0005729!7.15e-07!7 | |ontology_enrichment_uberon=UBERON:0000026!3.27e-09!12;UBERON:0004708!3.27e-09!12;UBERON:0002101!3.27e-09!12;UBERON:0004357!3.27e-09!12;UBERON:0004347!3.27e-09!12;UBERON:0005732!3.27e-09!12;UBERON:0005733!3.27e-09!12;UBERON:0003102!5.06e-09!22;UBERON:0010707!3.02e-08!13;UBERON:0002102!7.15e-07!7;UBERON:0004710!7.15e-07!7;UBERON:0005419!7.15e-07!7;UBERON:0005417!7.15e-07!7;UBERON:0005729!7.15e-07!7 | ||
|tfbs_overrepresentation_for_novel_motifs=0.19013,1.98314,0.171413,0.221468,0.325044,0.232532,0.305009,0.416085,0.768345,0.166154,0.26934,0.295134,0.416678,0.315149,0.108498,0,0.482714,0.645746,0.675828,0.599319,0.44813,0.424536,0.3144,1.10184,0.523846,0.338177,0.644752,0.248835,0.397744,1.14662,0.237846,0.574932,0.0927567,0.314034,0.108791,0.627341,0.0875334,0.292182,0.262298,0.0613737,0.318773,0.241862,1.18072,0.109711,0.118148,0.213039,0.41191,0.26128,0.725187,0.402574,0.467043,1.68982,1.10182,0.7073,0.723811,0.321095,0.417292,0.284741,0.611426,2.34586,0.556492,0.369066,0.813959,0.456979,0.330403,0.493315,0.854035,1.19441,0.552202,1.05011,0.158281,1.15547,0.0088675,0.755651,0.137983,0.546831,0.572907,0.401969,0.540754,0.455238,0.433876,1.24599,0.36783,0.400248,0.646739,0.00141663,1.63864,2.03178,0.416206,1.35441,0.92132,0.6514,0.586758,0.102076,0.073664,0.0648185,0.722691,0.589355,1.86606,0.0860851,0.614635,0.574674,0.690844,0.467576,0.466632,2.7321,0.52055,0.25809,0.152257,0.147333,0.185018,0.692526,0.894157,0.273484,0.928143,0.315992,0.0551807,0.224335,0.483885,0.289365,0.760792,0.438354,0.339713,0.40118,0.980682,1.34331,0.838247,0.580495,0.852575,0.691852,0.67485,3.37252,0.824167,0.332514,0.949083,7.1916,0.196278,1.95768,0.901468,1.71991,1.32292,0.85857,0.923442,0.584599,0.46084,0.242215,1.87461,1.68046,1.0906,0.0996378,0.0261402,0.0990985,0.708784,0.514688,0.331737,0.786435,0.361851,0.370626,0.188342,0.196072,0.910663,0.645939,0.544546,0.183389,0.457889,0.869172,0.293289,0.293837,0.256897 | |||
}} | }} |
Revision as of 18:22, 26 November 2012
Phase1 CAGE Peaks
Short description | |
---|---|
Mm9::chr10:106920848..106920852,- | p@chr10:106920848..106920852 - |
Mm9::chr10:106923133..106923146,- | p1@Myf5 |
Mm9::chr12:74140323..74140332,+ | p1@uc007nvz.1 |
Mm9::chr15:76993525..76993544,- | p@chr15:76993525..76993544 - |
Mm9::chr15:76993546..76993607,- | p@chr15:76993546..76993607 - |
Mm9::chr17:45738994..45739005,- | p1@Gm7325 |
Mm9::chr17:45739019..45739035,- | p3@Gm7325 |
Mm9::chr17:45739045..45739057,- | p2@Gm7325 |
Mm9::chr1:136186574..136186592,+ | p1@Myog |
Mm9::chr1:136186599..136186608,+ | p3@Myog |
Mm9::chr2:26927548..26927562,- | p4@Tmem8c |
Mm9::chr2:26927603..26927613,- | p5@Tmem8c |
Mm9::chr7:53631818..53631829,+ | p2@Myod1 |
Mm9::chr7:53631837..53631850,+ | p1@Myod1 |
Mm9::chr8:15060282..15060301,+ | p6@Myom2 |
Mm9::chr8:81337088..81337099,- | p5@Lsm6 |
Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data
GO ID | GO name | FDR corrected p-value |
---|---|---|
GO:0003705 | RNA polymerase II transcription factor activity, enhancer binding | 1.30825649872795e-06 |
GO:0007517 | muscle development | 2.24385378621871e-06 |
GO:0003702 | RNA polymerase II transcription factor activity | 3.14894467472946e-05 |
GO:0007519 | skeletal muscle development | 4.64273339264029e-05 |
GO:0014706 | striated muscle development | 7.90474854121923e-05 |
GO:0048741 | skeletal muscle fiber development | 0.00221721181591798 |
GO:0048747 | muscle fiber development | 0.00221721181591798 |
GO:0048513 | organ development | 0.00221721181591798 |
GO:0048625 | myoblast cell fate commitment | 0.00369210929248125 |
GO:0007518 | myoblast cell fate determination | 0.00369210929248125 |
GO:0048731 | system development | 0.00369210929248125 |
GO:0048856 | anatomical structure development | 0.00617794943570449 |
GO:0003700 | transcription factor activity | 0.00822184566576725 |
GO:0007275 | multicellular organismal development | 0.00822184566576725 |
GO:0016070 | RNA metabolic process | 0.00895309312046242 |
GO:0001952 | regulation of cell-matrix adhesion | 0.0157891795918016 |
GO:0010467 | gene expression | 0.0157891795918016 |
GO:0003676 | nucleic acid binding | 0.0157891795918016 |
GO:0008307 | structural constituent of muscle | 0.0157891795918016 |
GO:0032502 | developmental process | 0.0167022049410475 |
GO:0006139 | nucleobase, nucleoside, nucleotide and nucleic acid metabolic process | 0.0187434878481659 |
GO:0048704 | embryonic skeletal morphogenesis | 0.0187434878481659 |
GO:0032982 | myosin filament | 0.0203009953927489 |
GO:0005863 | striated muscle thick filament | 0.0203009953927489 |
GO:0005859 | muscle myosin complex | 0.0209858061922863 |
GO:0016460 | myosin II complex | 0.0222023357894868 |
GO:0048706 | embryonic skeletal development | 0.0222023357894868 |
GO:0048705 | skeletal morphogenesis | 0.0286850449302073 |
GO:0001709 | cell fate determination | 0.0286850449302073 |
GO:0048869 | cellular developmental process | 0.0286850449302073 |
GO:0030154 | cell differentiation | 0.0286850449302073 |
GO:0006402 | mRNA catabolic process | 0.0286850449302073 |
GO:0006941 | striated muscle contraction | 0.0286850449302073 |
GO:0006355 | regulation of transcription, DNA-dependent | 0.0286850449302073 |
GO:0043229 | intracellular organelle | 0.0286850449302073 |
GO:0006351 | transcription, DNA-dependent | 0.0286850449302073 |
GO:0043226 | organelle | 0.0286850449302073 |
GO:0032774 | RNA biosynthetic process | 0.0286850449302073 |
GO:0006401 | RNA catabolic process | 0.0286850449302073 |
GO:0003677 | DNA binding | 0.0286850449302073 |
GO:0005634 | nucleus | 0.0286850449302073 |
GO:0001756 | somitogenesis | 0.0286850449302073 |
GO:0032501 | multicellular organismal process | 0.0286850449302073 |
GO:0045449 | regulation of transcription | 0.0286850449302073 |
GO:0019219 | regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process | 0.0288343685554405 |
GO:0045445 | myoblast differentiation | 0.0288343685554405 |
GO:0043283 | biopolymer metabolic process | 0.0288343685554405 |
GO:0006350 | transcription | 0.0288343685554405 |
GO:0032991 | macromolecular complex | 0.0293743797132572 |
GO:0010468 | regulation of gene expression | 0.0303893002783488 |
GO:0035282 | segmentation | 0.0307669318902937 |
GO:0030155 | regulation of cell adhesion | 0.0321065380895143 |
GO:0031323 | regulation of cellular metabolic process | 0.0321065380895143 |
GO:0019222 | regulation of metabolic process | 0.0348980828944188 |
GO:0030198 | extracellular matrix organization and biogenesis | 0.0379645308585611 |
GO:0016459 | myosin complex | 0.0379645308585611 |
GO:0046982 | protein heterodimerization activity | 0.0392486596754975 |
GO:0042692 | muscle cell differentiation | 0.0398010198410609 |
GO:0007160 | cell-matrix adhesion | 0.0398010198410609 |
GO:0030017 | sarcomere | 0.0409223218011252 |
GO:0031589 | cell-substrate adhesion | 0.0409223218011252 |
GO:0044449 | contractile fiber part | 0.0414550571125855 |
GO:0030016 | myofibril | 0.0440876304488212 |
GO:0044424 | intracellular part | 0.0440876304488212 |
GO:0043292 | contractile fiber | 0.0440876304488212 |
GO:0003012 | muscle system process | 0.0460741289802003 |
GO:0006936 | muscle contraction | 0.0460741289802003 |
GO:0005200 | structural constituent of cytoskeleton | 0.0481049369305937 |
GO:0005622 | intracellular | 0.0490378524892453 |
GO:0009952 | anterior/posterior pattern formation | 0.0498838723759717 |
Relative expression of the co-expression cluster over median <br>Analyst:
Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br><br>uberon_data<br><br>
Ontology term | p-value | n |
---|---|---|
appendage | 3.27e-09 | 12 |
paired limb/fin | 3.27e-09 | 12 |
limb | 3.27e-09 | 12 |
paired limb/fin bud | 3.27e-09 | 12 |
limb bud | 3.27e-09 | 12 |
limb/fin field | 3.27e-09 | 12 |
limb field | 3.27e-09 | 12 |
surface structure | 5.06e-09 | 22 |
appendage girdle complex | 3.02e-08 | 13 |
forelimb | 7.15e-07 | 7 |
pectoral appendage | 7.15e-07 | 7 |
pectoral appendage bud | 7.15e-07 | 7 |
forelimb bud | 7.15e-07 | 7 |
forelimb/pectoral fin field | 7.15e-07 | 7 |
TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data
Novel motifs
JASPAR motifs
Motifs | -log10(p-value) |
---|---|
{{{tfbs_overrepresentation_jaspar}}} |